MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts

NEW YORK, June 5, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts
http://www.reportlinker.com/p01277582/MediPoint-Breast-Cancer-Imaging---US-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging

MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts

Summary

Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundation for increasing survival rates and diagnostic imaging is the most widely used technique to achieve early detection, making diagnostic imaging a cornerstone of breast cancer control.

The US breast cancer imaging market is a mature industry with complex dynamics and it is essential to examine the market opportunities and barriers that are specific to this region. This report provides an in-depth review of the evolving technologies and the regulatory landscape of the breast cancer screening market in the US.

Scope

- An overview of breast cancer, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized US Breast cancer imaging market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
- Investigation of current and future market competition for Breast cancer imaging
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Breast cancer imaging sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as radiologists

Reasons to buy

- Understand the trends shaping and driving the US Breast cancer imaging Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the US Breast cancer imaging Market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in US Breast cancer imaging market landscape? Identify, understand and capitalize.

Table of Contents

1 Table of Contents 5
1.1 List of Tables 12
1.2 List of Figures 17
2 Introduction 20
2.1 Catalyst 20
3 Disease Overview 21
3.1 Anatomy & Physiology of the Breast 21
3.2 Pathophysiology of Breast Cancer 22
3.3 Detection of Breast Cancer 22
3.4 Types of Breast Cancer 23
3.5 Clinical Presentation 25
3.6 Clinical Outcomes 26
3.6.1 Assessment Procedure 26
3.6.2 Screening Guidelines 29
3.7 Epidemiology of Breast Cancer 30
3.8 Economic Impact of Breast Cancer Imaging 32
4 Imaging Techniques 33
4.1 Mammography 33
4.1.1 Overview 33
4.1.2 Types of Mammography 35
4.2 Non-Mammographic Techniques 40
4.2.1 Breast Ultrasound Imaging 40
4.2.2 Breast Magnetic Resonance Imaging 41
4.3 Comparison of Mammography, Ultrasound, and MRI 42
4.4 Alternative Breast Imaging Techniques 43
4.4.1 Nuclear Imaging Techniques 44
4.4.2 Computed Tomography 45
4.4.3 Optical Breast Imaging 46
4.4.4 Electric Impedance-Based Techniques 46
4.4.5 Thermography 47
4.4.6 Elastography 47
4.4.7 Ductogram 47
5 Competitive Assessment 48
5.1 Overview 48
5.2 Film Screen Mammography 49
5.2.1 Performa (GE Healthcare) 49
5.2.2 Alpha RT/Alpha ST (GE Healthcare) 52
5.2.3 MAMMOMAT 1000 (Siemens Healthcare) 55
5.2.4 MAMMOMAT 3000 Nova (Siemens Healthcare) 57
5.2.5 M-IV/M-IV Platinum (Hologic) 59
5.2.6 MammoDiagnost (Philips Healthcare) 61
5.2.7 Planmed Nuance Classic (Planmed) 63
5.2.8 Planmed Sophie Classic (Planmed) 65
5.2.9 Analog Giotto Image (Internazionale Medico Scientifica) 66
5.2.10 HAWK-2M (Hologic) 68
5.2.11 MGU-1000A (Toshiba Medical Systems) 70
5.3 CR Mammography 71
5.3.1 Fuji Computed Radiography Mammography Suite (FCRMS) (Fujifilm Medical Systems) 71
5.3.2 KODAK DirectView (Carestream Health) 74
5.3.3 Xpress CR System (Konica Minolta) 75
5.3.4 REGIUS PureView (Konica Minolta) 77
5.3.5 Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) (Agfa Healthcare) 78
5.4 Full-Field Digital Mammography 80
5.4.1 Selenia Dimensions (Hologic) 80
5.4.2 Selenia (Hologic) 83
5.4.3 Selenia S (Hologic) 85
5.4.4 Selenia Performance (Hologic) 86
5.4.5 Senographe DS (GE Healthcare) 88
5.4.6 Senographe Essential (GE Healthcare) 89
5.4.7 Senographe Care (GE Healthcare) 92
5.4.8 SenoBright CESM (GE Healthcare) 93
5.4.9 MAMMOMAT Inspiration (Siemens Healthcare) 95
5.4.10 Aspire HD (US)/Amulet (Outside the US) (Fujifilm) 97
5.4.11 MammoDiagnost DR (Philips Healthcare) 100
5.4.12 MicroDose (Philips Healthcare) 102
5.4.13 Giotto Image 3D/3DL (Internazionale Medico Scientifica) 104
5.4.14 Planmed Nuance/Nuance Excel (Planmed) 106
5.4.15 Fairy DR (Allengers Medical Systems) 108
5.4.16 Serenity 109
5.5 3D Mammography 110
5.5.1 Selenia Dimensions 3D System (Hologic) 110
5.5.2 GE Breast Tomosynthesis (GE Healthcare) 112
5.5.3 True 3D Breast Tomosynthesis (Siemens Healthcare) 114
5.5.4 Giotto Tomo (Internazionale Medico Scientifica) 116
5.5.5 FUJIFILM 3Dimensional Mammography (Fujifilm) 118
5.6 Breast Ultrasound Imaging 120
5.6.1 somo.v Automated Breast Ultrasound (ABUS) (GE Healthcare) 120
5.6.2 SonoCine AWBUS (SonoCine) 122
5.6.3 ACUSON S2000 ABVS (Siemens Healthcare) 123
5.6.4 Terason t3200 Ultrasound System Breast Series (Terason Ultrasound) 125
5.7 Breast MRI 126
5.7.1 Aurora 1.5T Dedicated Breast MRI System (Aurora Imaging Technology) 126
5.8 Other Breast Imaging Techniques 128
5.8.1 PEM Flex Solo II (Naviscan) 128
5.8.2 Computerized Tomography Laser Mammography (CTLM) Model 1020 (Imaging Diagnostic Systems) 130
5.8.3 Dilon 6800/Dilon 6800 Acella (Dilon Diagnostics) 132
5.8.4 LumaGEM (Gamma Medica) 134
5.8.5 Discovery NM 750b (GE Healthcare) 136
6 Unmet Needs 139
6.1 Lower Radiation Dose 139
6.2 Increase Patient Comfort 140
6.3 Reduce False-Positives and False-Negatives 142
6.4 Loss of Sensitivity of Mammography in Dense Breasts 144
6.5 Unreliable Mammograms in Surgically-Operated Breasts and Breasts with Implants 146
6.6 Commitment to Training 147
7 Pipeline Products 149
7.1 Breast Cancer Imaging Pipeline Products Overview 149
7.2 MAMMOMAT Inspiration PRIME Edition 150
7.2.1 Overview 150
7.2.2 SWOT Analysis 150
7.3 MicroDose SI 151
7.3.1 Overview 151
7.3.2 SWOT Analysis 151
7.4 Selenia Dimensions 2D Contrast-Enhanced Digital Mammography (CEDM) 152
7.4.1 Overview 152
7.4.2 SWOT Analysis 152
7.5 SenoCase 153
7.5.1 Overview 153
7.5.2 SWOT Analysis 154
7.6 Electrical Mammogram 155
7.6.1 Overview 155
7.6.2 SWOT Analysis 155
8 Industry Overview 156
8.1 Purchasing Cycle 156
8.1.1 Product Life Cycle 156
8.1.2 Cost Effectiveness in Screening Settings 158
8.1.3 Cost-Effectiveness in Diagnostic Settings 158
8.2 Market Access 159
8.2.1 Purchasing Decisions 159
8.2.2 Regulatory Process 160
8.3 Quality Assurance 161
8.4 Adoption of New Technologies 161
8.4.1 Influence of Clinical Trials Results 161
8.4.2 Reimbursement 162
8.4.3 Economic Resources 163
8.4.4 Competitive Advantage 163
8.5 Current Reimbursement Trends 164
8.6 Trends in Detector Technology for Digital Mammography 165
8.7 Evolving Scatter-Removal Mechanisms 169
8.8 Overdiagnosis 171
8.9 Malpractice Litigations 172
8.10 Mergers and Acquisitions/Key Partnerships 173
8.10.1 GE Healthcare Acquires U-Systems 173
8.10.2 Koninklijke Philips Electronics Acquires MicroDose Mammography from Sectra 173
8.10.3 Hologic Acquires Beijing Healthcome Technology 174
8.10.4 Hologic Acquires Sentinelle Medical 174
8.10.5 Koninklijke Philips Electronics Acquires Shanghai Apex Electronics Technology 174
8.10.6 Fujifilm Medical Systems acquired FUJIFILM-RU 174
8.10.7 Other Key Events 175
9 Current and Future Players 176
9.1 Overview 176
9.2 Trends in Corporate Strategy 177
9.3 Company Profiles 178
9.3.1 GE Healthcare 178
9.3.2 Hologic 180
9.3.3 Siemens 182
9.3.4 Koninklijke Philips Electronics 183
9.3.5 Fujifilm Medical Systems 185
9.3.6 Internazionale Medico Scientifica (IMS) 186
9.3.7 Planmed 187
9.3.8 Konica Minolta Medical Imaging 188
9.3.9 Agfa Healthcare 189
9.3.10 Carestream Health 190
9.3.11 SonoCine 191
9.3.12 Aurora Imaging Technology 192
9.3.13 Imaging Diagnostic Systems 193
9.3.14 Naviscan 194
9.3.15 Dilon Diagnostics 195
9.3.16 Gamma Medica 195
10 Market Drivers & Opportunities 197
10.1 Market Drivers 197
10.1.1 Increase in the Incidence of Breast Cancer 197
10.1.2 Increased Awareness of the Benefits of Screening 197
10.1.3 Increased Breast Cancer Incidence Due to an Aging Population 198
10.1.4 FDA Reclassification of Mammography Equipment 198
10.1.5 New Technologies to Drive Market Growth 198
10.1.6 Adoption of Tomosynthesis in the US 200
10.2 Opportunities 202
10.2.1 Invest in Emerging Technologies 202
10.2.2 Product Improvement 203
10.3 Market Barriers 203
10.3.1 Shortage of Dedicated Mammography Professionals 203
10.3.2 Reduced Hospital Budgets 204
10.3.3 Refurbished Equipment Sales 204
10.3.4 Reimbursement 205
10.3.5 Substitutes 205
11 Country Outlooks & Forecasts 206
11.1 United States 206
11.1.1 United States Market Analysis 206
12 Appendix 210
12.1 Bibliography 210
12.2 Abbreviations 237
12.3 Report Methodology 241
12.3.1 Overview 241
12.3.2 Coverage 241
12.3.3 Secondary Research 241
12.3.4 Forecast Methodology 242
12.4 Physicians and Specialists Included in this Study 243
12.5 Primary Research 244
12.6 Physician Survey 244
12.7 About the Authors 245
12.7.1 Analysts 245
12.7.2 Global Head of Healthcare 246
12.8 Definitions 247
12.9 About MediPoint 247
12.10 About GlobalData 247
12.11 Contact Us 248
12.12 Disclaimer 248

List of Tables

Table 1: Breast Cancer Types, Including Diagnostic Procedures 24
Table 2: ACR Breast Imaging Reporting and Database System (BI-RADS) 26
Table 3: Selected Breast Cancer Incidence Rates, 2002 31
Table 4: Comparison of Mammography, Ultrasound, and MRI for Breast Imaging 42
Table 5: Performa Product Profile 50
Table 6: Performa SWOT Analysis 51
Table 7: Alpha RT/Alpha ST Product Profile 53
Table 8: Alpha RT/Alpha ST SWOT Analysis 54
Table 9: MAMMOMAT 1000 Product Profile 55
Table 10: MAMMOMAT 1000 SWOT Analysis 56
Table 11: MAMMOMAT 3000 Nova Product Profile 58
Table 12: MAMMOMAT 3000 Nova SWOT Analysis 58
Table 13: M-IV/M-IV Platinum Product Profile 60
Table 14: M-IV/M-IV Platinum SWOT Analysis 60
Table 15: MammoDiagnost Product Profile 62
Table 16: MammoDiagnost SWOT Analysis 62
Table 17: Planmed Nuance Classic Product Profile 64
Table 18: Planmed Nuance Classic SWOT Analysis 64
Table 19: Planmed Sophie Classic Product Profile 65
Table 20: Planmed Sophie Classic SWOT Analysis 66
Table 21: Analog Giotto Image Product Profile 67
Table 22: Analog Giotto Image SWOT Analysis 67
Table 23: HAWK-2M Product Profile 69
Table 24: HAWK-2M SWOT Analysis 69
Table 25: MGU-1000A Product Profile 70
Table 26: MGU-1000A SWOT Analysis 71
Table 27: Fuji Computed Radiography Mammography Suite (FCRMS) Product Profile 73
Table 28: Fuji Computed Radiography Mammography Suite (FCRMS) SWOT Analysis 73
Table 29: KODAK DirectView CR System Product Profile 74
Table 30: KODAK DirectView CR System SWOT Analysis 75
Table 31: Xpress CR System Product Profile 76
Table 32: Xpress CR System SWOT Analysis 76
Table 33: REGIUS PureView Product Profile 77
Table 34: REGIUS PureView SWOT Analysis 78
Table 35: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) Product Profile 79
Table 36: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) SWOT Analysis 79
Table 37: FFDM SWOT Analysis 80
Table 38: Selenia Dimensions Product Profile 81
Table 39: Selenia Dimensions SWOT Analysis 82
Table 40: Selenia Product Profile 84
Table 41: Selenia SWOT Analysis 84
Table 42: Selenia S Product Profile 85
Table 43: Selenia S SWOT Analysis 86
Table 44: Selenia Performance Product Profile 87
Table 45: Selenia Performance SWOT Analysis 87
Table 46: Senographe DS Product Profile 88
Table 47: Senographe DS SWOT Analysis 89
Table 48: Senographe Essential/Senographe Essential E Product Profile 90
Table 49: Senographe Essential SWOT Analysis 91
Table 50: Senographe Care Product Profile 92
Table 51: Senographe Care SWOT Analysis 93
Table 52: SenoBright CESM Product Profile 94
Table 53: SenoBright CESM SWOT Analysis 95
Table 54: MAMMOMAT Inspiration Product Profile 96
Table 55: MAMMOMAT Inspiration SWOT Analysis 97
Table 56: Aspire HD/Amulet Product Profile 98
Table 57: Aspire HD/Amulet SWOT Analysis 99
Table 58: MammoDiagnost DR Product Profile 100
Table 59: MammoDiagnost DR SWOT Analysis 101
Table 60: MicroDose Product Profile 103
Table 61: MicroDose SWOT Analysis 103
Table 62: Giotto Image 3D/3DL Product Profile 105
Table 63: Giotto Image 3D/3DL SWOT Analysis 105
Table 64: Planmed Nuance/Nuance Excel Product Profile 107
Table 65: Planmed Nuance/Nuance Excel SWOT Analysis 107
Table 66: Fairy DR Product Profile 108
Table 67: Fairy DR SWOT Analysis 109
Table 68: Serenity Product Profile 110
Table 69: Serenity SWOT Analysis 110
Table 70: Selenia Dimensions 3D System Product Profile 111
Table 71: Selenia Dimensions SWOT Analysis 112
Table 72: GE Breast Tomosynthesis Product Profile 113
Table 73: GE Breast Tomosynthesis SWOT Analysis 114
Table 74: True 3D Breast Tomosynthesis Product Profile 115
Table 75: True 3D Breast Tomosynthesis SWOT Analysis 116
Table 76: Giotto Tomo Product Profile 117
Table 77: Giotto Tomo SWOT Analysis 118
Table 78: FUJIFILM 3Dimensional Mammography Product Profile 119
Table 79: FUJIFILM 3Dimensional Mammography SWOT Analysis 119
Table 80: somo.v ABUS Product Profile 121
Table 81: somo.v ABUS SWOT Analysis 121
Table 82: SonoCine AWBUS Product Profile 122
Table 83: SonoCine AWBUS SWOT Analysis 123
Table 84: ACUSON S2000 ABVS Product Profile 124
Table 85: Acuson S2000 ABVS SWOT Analysis 125
Table 86: Terason t3200 Ultrasound System Breast Series Product Profile 126
Table 87: Terason t3200 Ultrasound System Breast Series SWOT Analysis 126
Table 88: Aurora 1.5T Dedicated Breast MRI System Product Profile 127
Table 89: Aurora 1.5T Dedicated Breast SWOT Analysis 128
Table 90: PEM Flex Solo II Product Profile 129
Table 91: PEM Flex Solo II SWOT Analysis 130
Table 92: Computerized Tomography Laser Mammography (CTLM) Model 1020 Product Profile 131
Table 93: Computerized Tomography Laser Mammography (CTLM) Model 1020 SWOT Analysis 132
Table 94: Dilon 6800/Dilon 6800 Acella Product Profile 134
Table 95: Dilon 6800/Dilon 6800 Acella SWOT Analysis 134
Table 96: LumaGEM Product Profile 135
Table 97: LumaGEM SWOT Analysis 136
Table 98: Discovery NM 750b Product Profile 137
Table 99: Discovery NM 750b SWOT Analysis 138
Table 100: Breast Cancer Imaging Pipeline Products 149
Table 101: MAMMOMAT Inspiration PRIME Edition SWOT Analysis 150
Table 102: Philips MicroDose SI SWOT Analysis 151
Table 103: Selenia Dimensions 2D Contrast Imaging SWOT Analysis 152
Table 104: SenoCase SWOT Analysis 154
Table 105: Electrical Mammogram SWOT Analysis 155
Table 106: Other Key Events in the Breast Cancer Imaging Market 175
Table 107: GE Healthcare SWOT Analysis, 2013 180
Table 108: Hologic SWOT Analysis, 2013 182
Table 109: Siemens SWOT Analysis, 2013 183
Table 110: Koninklijke Philips Electronics SWOT Analysis, 2013 184
Table 111: Fujifilm Medical Systems, SWOT Analysis, 2013 185
Table 112: Internazionale Medico Scientifica SWOT Analysis, 2013 186
Table 113: Planmed, SWOT Analysis, 2013 187
Table 114: Konica Minolta Medical Imaging, SWOT Analysis, 2013 188
Table 115: Agfa Healthcare, SWOT Analysis, 2013 189
Table 116: Carestream Health, SWOT Analysis, 2013 190
Table 117: SonoCine, SWOT Analysis, 2013 191
Table 118: Aurora Imaging Technology, SWOT Analysis, 2013 192
Table 119: Imaging Diagnostic Systems, SWOT Analysis, 2013 194
Table 120: Naviscan, SWOT Analysis, 2013 194
Table 121: Dilon Diagnostics, SWOT Analysis, 2013 195
Table 122: Gamma Medica, SWOT Analysis, 2013 196
Table 123: Sales Forecasts for Breast Cancer Imaging in the US, 2009–2018 206
Table 124: Number of Installations of New Breast Imaging Systems in the US, 2011 and 2018 208
Table 125: Physicians Surveyed, By Country 244

List of Figures

Figure 1: Anatomy of the Breast 21
Figure 2: Breast Cancer Screening, Diagnostic Evaluation, and Follow-Up 27
Figure 3: Percentage Use of Ultrasound Imaging and MRI for Breast Cancer Screening and Follow-Up, 2009–2016 28
Figure 4: Breast Cancer Risk Factors 30
Figure 5: Projected US Trends in Breast Cancer Incidence, 2012–2018 31
Figure 6: Comparison Between Digital (FFDM) and Analog (FSM) Mammography 36
Figure 7: Use of Alternative Breast Imaging Modalities, 2009–2016 43
Figure 8: Performa 50
Figure 9: Alpha RT 52
Figure 10: Alpha ST 53
Figure 11: MAMMOMAT 1000 55
Figure 12: MAMMOMAT 3000 Nova 57
Figure 13: M-IV/M-IV Platinum 59
Figure 14: MammoDiagnost 61
Figure 15: Planmed Nuance Classic 63
Figure 16: Planmed Sophie Classic 65
Figure 17: Analog Giotto Image 66
Figure 18: HAWK-2M 68
Figure 19: MGU-1000A 70
Figure 20: Aspire CRm 72
Figure 21: KODAK DirectView CR System 74
Figure 22: Xpress CR System 75
Figure 23: REGIUS PureView Type M 77
Figure 24: DX-M Digitizer 78
Figure 25: Selenia Dimensions 81
Figure 26: Selenia 83
Figure 27: Selenia S 85
Figure 28: Selenia Performance 86
Figure 29: Senographe DS 88
Figure 30: Senographe Essential 90
Figure 31: Senographe Care 92
Figure 32: SenoBright CESM* 94
Figure 33: MAMMOMAT Inspiration 96
Figure 34: Aspire HD 98
Figure 35: MammoDiagnost DR 100
Figure 36: MicroDose 102
Figure 37: Giotto Image 3D/3DL 104
Figure 38: Planmed Nuance/Nuance Excel 106
Figure 39: Fairy DR 108
Figure 40: Serenity 109
Figure 41: Selenia Dimensions 2D System 111
Figure 42: Senographe Essential 113
Figure 43: True 3D Breast Tomosynthesis* 115
Figure 44: Giotto Tomo 117
Figure 45: Fujifilm 3D Mammography Viewer 119
Figure 46: somo.v ABUS 120
Figure 47: SonoCine AWBUS 122
Figure 48: ACUSON S2000 ABVS 124
Figure 49: Terason t3200 Ultrasound System Breast Series 125
Figure 50: Aurora 1.5T Dedicated Breast MRI System 127
Figure 51: PEM Flex Solo II 129
Figure 52: CTLM Model 1020 131
Figure 53: Dilon 6800 Acella 133
Figure 54: Dilon 6800 133
Figure 55: LumaGEM 135
Figure 56: Discovery NM 750b 137
Figure 57: Percentage of False-Positive, False-Negative and Accurate Breast Cancer Diagnoses from 2011–2012 143
Figure 58: SenoCase 153
Figure 59: Product Life Cycle 157
Figure 60: Detector Evolution 165
Figure 61: Comparison Between a Typical Direct Conversion Detector and a Direct Optical Switching Detector 167
Figure 62: Photon-Counting Detector Technology 169
Figure 63: Linear and High Transmission Cellular Grids 170
Figure 64: Increase in FFDM Systems in the US, 2004–2013 200
Figure 65: Trends in the Use of Mammographic Techniques, 2009–2016 201
Figure 66: Sales Forecasts for Breast Cancer Imaging in the US, 2009–2018 206
Figure 67: Total Number of Breast Imaging Facilities and Total Number of Facilities with FFDM Units in the US, 2008–2013 207
Figure 68: Percentage of Installations of New Breast Imaging Systems in the US in 2011 and 2018 209

Companies Mentioned

GE Healthcare
Hologic
Siemens
Koninklijke Philips Electronics
Fujifilm Medical Systems
Internazionale Medico Scientifica (IMS)
Planmed
Konica Minolta Medical Imaging
Agfa Healthcare
Carestream Health
SonoCine
Aurora Imaging Technology
Imaging Diagnost

To order this report:
Medical_Imaging Industry:
MediPoint: Breast Cancer Imaging - US Analysis and Market Forecasts


Contact Clare: clare@reportlinker.com  
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.